Search for in this collection

Subscribe to this collection to receive daily e-mail notification of new additions

Preview	Issue Date	Title / Name	Author(s)
	Jun-2007	Re: Radiation oncology clinical audit: a matter of behaviour and performance	Shakespeare, T. P.; Toohey, J. M.; Shakespeare, Thomas P.
	May-2005	Evaluation of the quality of radiotherapy randomized trials for painful bone metastases	Shakespeare, T. P.; Thiagarajan, A.; Gabski, V.; Shakespeare, Thomas P.
	Mar-2007	Does the implementation of radiation oncology outpatient infection control measures adversely affect patient satisfaction with doctor-patient interaction?	Shakespeare, T. P.; Tang, J. I.; Lu, J. J.; Mukherjee, R. K.; Lee, K. M.; Wynne, C. J.; Back, M. F.; Shakespeare, Thomas P.
	2005	Evaluation of an audit with feedback continuing medical education program for radiation oncologists	Shakespeare, T. P.; Mukherjee, R. K.; Lu, J. J.; Lee, K. M.; Back, M. F.; Shakespeare, Thomas P.
	Jan-2006	Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: Is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?	Back, M.; Shakespeare, T. P.; Lim, K. H. C.; Mukherjee, R. K.; Lu, J. D.; Shakespeare, Thomas P.
	Dec-2019	PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years	Shakespeare, T. P.; Eggert, E.; Wood, M.; Westhuyzen, J.; Turnbull, K.; Rutherford, N.; Aherne, N.; Shakespeare, Thomas P.; Eggert, Elizabeth; Wood, Maree; Westhuyzen, Justin; Turnbull, Kirsty; Aherne, Noel
	Feb-2017	Long-term decision regret after post-prostatectomy image-guided intensity-modulated radiotherapy	Shakespeare, T. P.; Chin, S.; Manuel, L.; Wen, S.; Hoffmann, M.; Wilcox, S. W.; Aherne, N. J.; Shakespeare, Thomas P.; Chin, Stephen; Hoffmann, Matthew; Wilcox, Shea; Aherne, Noel
	Oct-2016	Long-Term Decision Regret After Postprostatectomy Image Guided Intensity Modulated Radiation Therapy	Shakespeare, T. P.; Chin, S.; Hoffmann, M.; Aherne, N.; Shakespeare, Thomas P.; Hoffmann, Matthew; Aherne, Noel
	Mar-2006	External audit of clinical practice and medical decision making in a new Asian oncology center: results and implications for both developing and developed nations	Shakespeare, T. P.; Back, M. F.; Lu, J. J.; Lee, K. M.; Mukherjee, R. K.; Shakespeare, Thomas P.
	Apr-2016	Adjuvant radiotherapy after radical prostatectomy: A failure of marketing-based medicine?	Shakespeare, T. P.; Shakespeare, Thomas P.
	27-Mar-2024	Use of artificial intelligence in breast surgery: a narrative review	Seth, I.; Lim, B.; Joseph, K.; Gracias, D.; Xie, Y.; Ross, R. J.; Rozen, W. M.; Joseph, Konrad
	Nov-2015	Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists	Shakespeare, T. P.; Shakespeare, Thomas P.
	Dec-2003	Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial	Scheithauer, W.; McKendrick, J.; Begbie, S.; Borner, M.; Burns, W. I.; Burris, H. A.; Cassidy, J.; Jodrell, D.; Koralewski, P.; Levine, E. L.; Marschner, N.; Maroun, J.; Garcia-Alfonso, P.; Tujakowski, J.; Van Hazel, G.; Wong, A.; Zaluski, J.; Twelves, C.; Begbie, Stephen
	Oct-2024	Quality management of head and neck patient treatments using statistical process control techniques	Sandford, M. J.; Steel, J. G.; Goodworth, J. R.; Lodge, P. J.; Sandford, Michael J.; Steel, Jared G.; Goodworth, Josie R.
	Oct-2022	Impact of radiation oncology research grants awarded by the Royal Australian and New Zealand College of Radiologists using the "Payback Framework".	Roos, D.; Ramsay, B.; Sullivan, L.; Sundaresan, P.; Ramsay, Ben
	Aug-2016	The effect of pulmonary function testing on bleomycin dosing in germ cell tumours	Roncolato, F. T.; Chatfield, M.; Houghton, B.; Toner, G.; Stockler, M.; Thomson, D.; Friedlander, M.; Gurney, H.; Rosenthal, M.; Grimison, P.; Houghton, Baerin
	May-2024	Four-year outcomes and circulating tumor DNA (ctDNA) analysis of pembrolizumab (pembro) plus concurrent chemoradiation therapy (cCRT) in unresectable, locally advanced, stage III non–small-cell lung cancer (NSCLC): From KEYNOTE-799.	Reck, M.; Lee, K. H.; Frost, N.; Breder, V. V.; Kowalski, D. M.; Levchenko, E.; Reguart, N.; Martinez-Marti, A.; Houghton, B.; Paoli, J. B.; Safina, S.; Liu, H.; Novinskiy, V.; Dettman, E. J.; Kobie, J.; Jabbour, S. K.; Houghton, Baerin
	2010	Prostate cancer : your guide to the disease, treatment options and outcomes, 3rd Edition	Rashid, P.; Rashid, Prem
	2003	Your guide to prostate cancer : the disease, treatment options & outcomes	Rashid, P.; Rashid, Prem
	Sep-2015	Monte Carlo-based dose calculation in postprostatectomy image-guided intensity modulated radiotherapy: A pilot study	Rankine, A.; Turnbull, K.; Greenham, S.; Shakespeare, T. P.; Westhuyzen, J.; Kovendy, A.; Chua, B.; McKay, M. J.; Turnbull, Kirsty; Shakespeare, Thomas P.; Westhuyzen, Justin; Kovendy, Andrew; McKay, Michael J.